What are the treatment options for conjunctivitis (pink eye)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Conjunctivitis (Pink Eye)

Treatment for pink eye depends entirely on the underlying cause: topical broad-spectrum antibiotics for bacterial conjunctivitis, topical antihistamines with mast cell-stabilizing properties for allergic conjunctivitis, and supportive care only for viral conjunctivitis. 1, 2

Initial Classification by Clinical Presentation

The first step is determining the type of conjunctivitis based on key clinical features:

  • Bacterial conjunctivitis: Yellow crusting around the eyes, mucopurulent discharge, eyelids matted shut upon waking, absence of itching 3, 4
  • Viral conjunctivitis: Watery discharge, burning/gritty sensation, often preceded by upper respiratory infection 4, 5
  • Allergic conjunctivitis: Bilateral itching (most consistent sign), watery discharge, seasonal pattern 6, 7

Treatment by Type

Bacterial Conjunctivitis

Mild cases are self-limited and resolve spontaneously in 1-2 weeks without treatment in immunocompetent adults 3, 6

Moderate to severe cases (copious purulent discharge, marked inflammation):

  • Prescribe a 5-7 day course of broad-spectrum topical antibiotic 1, 3
  • Topical fluoroquinolones (moxifloxacin, levofloxacin, gatifloxacin, ciprofloxacin, besifloxacin) are effective against common pathogens including S. aureus, S. pneumoniae, and H. influenzae 2
  • Alternative options include bacitracin ointment applied 1-3 times daily 8 or erythromycin ointment 9
  • No single antibiotic has proven superiority over another; choice can be based on dosing convenience, cost, and local resistance patterns 2
  • Instruct patients to clean eyelids with warm water before applying medication 3
  • Advise return if no improvement after 3-4 days 1, 3

Special bacterial cases requiring systemic antibiotics:

  • Gonococcal conjunctivitis: Ceftriaxone 250 mg IM single dose plus azitromicin 1 g oral single dose; requires daily follow-up until resolution 1, 2
  • Chlamydial conjunctivitis: Azithromycin 1 g oral single dose OR doxycycline 100 mg oral twice daily for 7 days; treat sexual contacts concurrently 1, 3, 2
  • In resource-limited settings, povidone-iodine 1.25% ophthalmic solution can substitute for chlamydial treatment 10, 1

Viral Conjunctivitis

No specific antiviral treatment exists for adenoviral conjunctivitis (80% of viral cases) 5, 7

Supportive care includes:

  • Refrigerated preservative-free artificial tears 4 times daily to dilute viral particles 2
  • Cold compresses 1, 3
  • Topical antihistamines for symptomatic relief of itching 2
  • Avoid topical antibiotics as they provide no benefit and risk toxicity 3, 2
  • Avoid topical corticosteroids as they can prolong adenoviral infections 1, 3

Herpes simplex virus (HSV) conjunctivitis requires specific treatment:

  • Topical ganciclovir 0.15% gel OR topical trifluridine 1% solution 2
  • Oral antivirals (acyclovir, valacyclovir, or famciclovir) may also be used 2
  • Never use topical corticosteroids without antiviral coverage as they potentiate HSV infection 2

Allergic Conjunctivitis

First-line treatment:

  • Topical antihistamines with mast cell-stabilizing properties (e.g., olopatadine, ketotifen) are the treatment of choice 1, 3, 2
  • Simple measures: sunglasses as allergen barriers, cold compresses, refrigerated artificial tears 1, 3

Persistent or recurrent cases:

  • Mast cell stabilizers (cromolyn sodium) for prophylaxis 1, 3

Severe cases:

  • Brief 1-2 week course of low side-effect profile topical corticosteroids (fluorometholone, loteprednol, or rimexolone) 1, 3
  • Monitor intraocular pressure and for cataract formation if corticosteroids are used 3, 2

Infection Control Measures

  • Strict handwashing with soap and water to prevent transmission 2
  • Avoid sharing towels, pillows, or cosmetics 1
  • Discontinue contact lens wear until complete resolution 1, 3
  • Discard multiple-dose eyedrop containers to avoid cross-contamination 2
  • Viral conjunctivitis patients should avoid close contact for 7-14 days from symptom onset 2

Mandatory Ophthalmology Referral

Immediate referral is required for: 10, 1, 3

  • Visual loss
  • Moderate or severe pain
  • Severe purulent discharge
  • Corneal involvement
  • Conjunctival scarring
  • Lack of response to therapy after 3-4 days
  • Recurrent episodes
  • History of HSV eye disease
  • Immunocompromised state
  • Neonatal conjunctivitis (mandatory hospitalization) 1, 2

Critical Pitfalls to Avoid

  • Failing to treat sexual contacts concurrently in gonococcal or chlamydial conjunctivitis leads to reinfection 1, 3
  • Consider sexual abuse in children with gonococcal or chlamydial conjunctivitis; reporting may be mandatory 10, 1
  • Using topical corticosteroids in HSV conjunctivitis without antiviral coverage worsens infection 3, 2
  • Indiscriminate antibiotic use in viral conjunctivitis causes unnecessary toxicity 1, 3
  • Prolonged trifluridine use (>2 weeks) causes epithelial toxicity 2
  • Chronic vasoconstrictor use causes rebound vasodilation 3
  • Oral antihistamines may worsen dry eye syndrome 3

References

Guideline

Treatment of Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Conjunctivitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Conjunctivitis: Diagnosis and Management.

American family physician, 2024

Research

Viral Conjunctivitis.

Viruses, 2023

Research

Conjunctivitis: A Systematic Review.

Journal of ophthalmic & vision research, 2020

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.